These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 8033104
1. The human DNA repair gene, ERCC2 (XPD), corrects ultraviolet hypersensitivity and ultraviolet hypermutability of a shuttle vector replicated in xeroderma pigmentosum group D cells. Gözükara EM, Parris CN, Weber CA, Salazar EP, Seidman MM, Watkins JF, Prakash L, Kraemer KH. Cancer Res; 1994 Jul 15; 54(14):3837-44. PubMed ID: 8033104 [Abstract] [Full Text] [Related]
2. Recovery of normal DNA repair and mutagenesis in trichothiodystrophy cells after transduction of the XPD human gene. Marionnet C, Quilliet X, Benoit A, Armier J, Sarasin A, Stary A. Cancer Res; 1996 Dec 01; 56(23):5450-6. PubMed ID: 8968100 [Abstract] [Full Text] [Related]
3. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D. Takayama K, Salazar EP, Lehmann A, Stefanini M, Thompson LH, Weber CA. Cancer Res; 1995 Dec 01; 55(23):5656-63. PubMed ID: 7585650 [Abstract] [Full Text] [Related]
4. An SV40-transformed xeroderma pigmentosum group D cell line: establishment, ultraviolet sensitivity, transfection efficiency and plasmid mutation induction. Protić-Sabljić M, Seetharam S, Seidman MM, Kraemer KH. Mutat Res; 1986 Nov 01; 166(3):287-94. PubMed ID: 3023995 [Abstract] [Full Text] [Related]
5. Expression of a transfected DNA repair gene (XPA) in xeroderma pigmentosum group A cells restores normal DNA repair and mutagenesis of UV-treated plasmids. Levy DD, Saijo M, Tanaka K, Kraemer KH. Carcinogenesis; 1995 Jul 01; 16(7):1557-63. PubMed ID: 7614689 [Abstract] [Full Text] [Related]
6. Structural and mutational analysis of the xeroderma pigmentosum group D (XPD) gene. Frederick GD, Amirkhan RH, Schultz RA, Friedberg EC. Hum Mol Genet; 1994 Oct 01; 3(10):1783-8. PubMed ID: 7849702 [Abstract] [Full Text] [Related]
7. Stable transformation of xeroderma pigmentosum group A cells with an XPA minigene restores normal DNA repair and mutagenesis of UV-treated plasmids. Myrand SP, Topping RS, States JC. Carcinogenesis; 1996 Sep 01; 17(9):1909-17. PubMed ID: 8824513 [Abstract] [Full Text] [Related]
8. Correction by the ERCC2 gene of UV sensitivity and repair deficiency phenotype in a subset of trichothiodystrophy cells. Mezzina M, Eveno E, Chevallier-Lagente O, Benoit A, Carreau M, Vermeulen W, Hoeijmakers JH, Stefanini M, Lehmann AR, Weber CA. Carcinogenesis; 1994 Aug 01; 15(8):1493-8. PubMed ID: 8055625 [Abstract] [Full Text] [Related]
9. Characteristics of UV-induced mutation spectra in human XP-D/ERCC2 gene-mutated xeroderma pigmentosum and trichothiodystrophy cells. Marionnet C, Benoit A, Benhamou S, Sarasin A, Stary A. J Mol Biol; 1995 Oct 06; 252(5):550-62. PubMed ID: 7563073 [Abstract] [Full Text] [Related]
10. Analysis of point mutations in an ultraviolet-irradiated shuttle vector plasmid propagated in cells from Japanese xeroderma pigmentosum patients in complementation groups A and F. Yagi T, Tatsumi-Miyajima J, Sato M, Kraemer KH, Takebe H. Cancer Res; 1991 Jun 15; 51(12):3177-82. PubMed ID: 2039995 [Abstract] [Full Text] [Related]
11. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms. Kobayashi T, Kuraoka I, Saijo M, Nakatsu Y, Tanaka A, Someda Y, Fukuro S, Tanaka K. Hum Mutat; 1997 Jun 15; 9(4):322-31. PubMed ID: 9101292 [Abstract] [Full Text] [Related]
12. Ultraviolet hypermutability of a shuttle vector propagated in xeroderma pigmentosum variant cells. Waters HL, Seetharam S, Seidman MM, Kraemer KH. J Invest Dermatol; 1993 Nov 15; 101(5):744-8. PubMed ID: 8228338 [Abstract] [Full Text] [Related]
13. Restoration of nucleotide excision repair in a helicase-deficient XPD mutant from intragenic suppression by a trichothiodystrophy mutation. George JW, Salazar EP, Vreeswijk MP, Lamerdin JE, Reardon JT, Zdzienicka MZ, Sancar A, Kadkhodayan S, Tebbs RS, Mullenders LH, Thompson LH. Mol Cell Biol; 2001 Nov 15; 21(21):7355-65. PubMed ID: 11585917 [Abstract] [Full Text] [Related]
14. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients. Carreau M, Quilliet X, Eveno E, Salvetti A, Danos O, Heard JM, Mezzina M, Sarasin A. Hum Gene Ther; 1995 Oct 15; 6(10):1307-15. PubMed ID: 8590735 [Abstract] [Full Text] [Related]
15. Effects of XPD mutations on ultraviolet-induced apoptosis in relation to skin cancer-proneness in repair-deficient syndromes. Queille S, Drougard C, Sarasin A, Daya-Grosjean L. J Invest Dermatol; 2001 Nov 15; 117(5):1162-70. PubMed ID: 11710928 [Abstract] [Full Text] [Related]
16. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy. Boyle J, Ueda T, Oh KS, Imoto K, Tamura D, Jagdeo J, Khan SG, Nadem C, Digiovanna JJ, Kraemer KH. Hum Mutat; 2008 Oct 15; 29(10):1194-208. PubMed ID: 18470933 [Abstract] [Full Text] [Related]
17. Long-term complementation of DNA repair deficient human primary fibroblasts by retroviral transduction of the XPD gene. Quilliet X, Chevallier-Lagente O, Eveno E, Stojkovic T, Destée A, Sarasin A, Mezzina M. Mutat Res; 1996 Dec 02; 364(3):161-9. PubMed ID: 8960128 [Abstract] [Full Text] [Related]
18. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Taylor EM, Broughton BC, Botta E, Stefanini M, Sarasin A, Jaspers NG, Fawcett H, Harcourt SA, Arlett CF, Lehmann AR. Proc Natl Acad Sci U S A; 1997 Aug 05; 94(16):8658-63. PubMed ID: 9238033 [Abstract] [Full Text] [Related]
19. Efficient repair of 8-oxo-7,8-dihydrodeoxyguanosine in human and hamster xeroderma pigmentosum D cells. Cappelli E, Degan P, Thompson LH, Frosina G. Biochemistry; 2000 Aug 29; 39(34):10408-12. PubMed ID: 10956030 [Abstract] [Full Text] [Related]
20. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Broughton BC, Berneburg M, Fawcett H, Taylor EM, Arlett CF, Nardo T, Stefanini M, Menefee E, Price VH, Queille S, Sarasin A, Bohnert E, Krutmann J, Davidson R, Kraemer KH, Lehmann AR. Hum Mol Genet; 2001 Oct 15; 10(22):2539-47. PubMed ID: 11709541 [Abstract] [Full Text] [Related] Page: [Next] [New Search]